# The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes

> **NCT01181986** · PHASE4 · COMPLETED · sponsor: **Carl T. Hayden VA Medical Center** · enrollment: 76 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Exenatide SC
- **DRUG:** Exenatide IV
- **DRUG:** Placebo SC
- **DRUG:** Exendin-9
- **DRUG:** Placebo IV

## Key facts

- **NCT ID:** NCT01181986
- **Lead sponsor:** Carl T. Hayden VA Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2014-05-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01181986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01181986, "The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01181986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*